Whereas we encountered a patient with a leukemic presentation of a small cell variant whose circulating small tumor cells exhibited low expression of CD30 and ALK on immunohistochemistry and flow cytometry, with only one-tenth of NPM-ALK mRNA expression compared to large tumor cells [21]. This evidence concerns the gene ALK and neoplasm.